Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial

Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial

Background and objectiveLong-course (LC) antidepressants for the treatment of disorders of gut-brain interaction, such as refractory functional dyspepsia (rFD), pose patients at risk of antidepressant discontinuation syndrome (ADS). Short-course (SC) therapy of rapid-acting antidepressant may reduce...

Full description

Bibliographic Details
Main Authors: Qian-Qian Wang, Li Cheng, Bi-Yu Wu, Ping Xu, Hong-Yi Qiu, Bo Wang, Xiu-Juan Yan, Sheng-Liang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Psychiatry
Subjects:
neuromodulator
antidepressant discontinuation syndrome
psychosomatic disease
functional dyspepsia
flupentixol-melitracen
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1063722/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1063722/full

Similar Items